Stay updated with breaking news from Pharmacovigilance Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Indian Pharmacopoeia Commission (IPC) issued a drug safety alert for painkiller ‘Meftal’. Here are some pointers that parents should know to treat fever in kids | Health
A shortlist of the biggest headlines, recommended stories, and a collection of news events to check out. | Latest News India
Blue Cross Laboratories, the owner of the Meftal painkiller brand, has clarified that the adverse reaction the Indian Pharmacopoeia Commission (IPC) has flagged is a rare event. The company claims that the product's constituent, mefenamic acid, can cause adverse reactions, including eosinophilia and systemic symptoms (DRESS) syndrome.
Get Meftal latest news, Article video and Photos on Meftal Explore latest health updates, news, information from TheHealthSite.com
What Is So Dangerous About The Meftal Painkiller? Let's take a quick look. TheHealthSite.com